Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

G.J. Hankey; J.W. Eikelboom; Q Yi; K.R. Lees; C. Chen; D. Xavier; J.C. Navarro; U.K. Ranawaka; W. Uddin; S. Ricci; J. Gommans; A. Algra; M. Kapelle; A.F. Schmidt; Group VITATOPS Trial Study Group

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

G.J. Hankey, J.W. Eikelboom, Q Yi, K.R. Lees, C. Chen, D. Xavier, J.C. Navarro, U.K. Ranawaka, W. Uddin, S. Ricci, J. Gommans, A. Algra, M. Kapelle, A.F. Schmidt, Group VITATOPS Trial Study Group

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	512-520
Number of pages	9
Journal	Lancet Neurology
Volume	11
Issue number	6
Publication status	Published - 2012

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22554931H

Cite this

Hankey, G. J., Eikelboom, J. W., Yi, Q., Lees, K. R., Chen, C., Xavier, D., Navarro, J. C., Ranawaka, U. K., Uddin, W., Ricci, S., Gommans, J., Algra, A., Kapelle, M., Schmidt, A. F., & VITATOPS Trial Study Group, G. (2012). Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial. Lancet Neurology, 11(6), 512-520. http://www.ncbi.nlm.nih.gov/pubmed/22554931H

@article{8e5ad4d399674a0e8178c9dd0fd905df,

title = "Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "G.J. Hankey and J.W. Eikelboom and Q Yi and K.R. Lees and C. Chen and D. Xavier and J.C. Navarro and U.K. Ranawaka and W. Uddin and S. Ricci and J. Gommans and A. Algra and M. Kapelle and A.F. Schmidt and {VITATOPS Trial Study Group}, Group",

year = "2012",

language = "English",

volume = "11",

pages = "512--520",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Limited",

number = "6",

}

Hankey, GJ, Eikelboom, JW, Yi, Q, Lees, KR, Chen, C, Xavier, D, Navarro, JC, Ranawaka, UK, Uddin, W, Ricci, S, Gommans, J, Algra, A, Kapelle, M, Schmidt, AF & VITATOPS Trial Study Group, G 2012, 'Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.', Lancet Neurology, vol. 11, no. 6, pp. 512-520. <http://www.ncbi.nlm.nih.gov/pubmed/22554931H>

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial. / Hankey, G.J.; Eikelboom, J.W.; Yi, Q et al.
In: Lancet Neurology, Vol. 11, No. 6, 2012, p. 512-520.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

AU - Hankey, G.J.

AU - Eikelboom, J.W.

AU - Yi, Q

AU - Lees, K.R.

AU - Chen, C.

AU - Xavier, D.

AU - Navarro, J.C.

AU - Ranawaka, U.K.

AU - Uddin, W.

AU - Ricci, S.

AU - Gommans, J.

AU - Algra, A.

AU - Kapelle, M.

AU - Schmidt, A.F.

AU - VITATOPS Trial Study Group, Group

PY - 2012

Y1 - 2012

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 1474-4422

VL - 11

SP - 512

EP - 520

JO - Lancet Neurology

JF - Lancet Neurology

IS - 6

ER -